Advertisement

Indian

Serum likely to supply COVID-19 vaccine at over $3 a dose to Indian government

The government is pinning its hopes for mass supply on Serum Institute, which lodged the first formal application for emergency-use approval of AstraZeneca’s shot on Monday.

Chief Executive Officer Adar Poonawalla had earlier said the vaccine would be priced at 1,000 rupees ($13.55) per dose in India’s private market, but governments signing large supply deals would likely buy it at lower prices.

International

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Briefs

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Events

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Advertisement

Articles

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Features

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Data

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Interviews

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Facts

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.